治疗方法 菌根杆菌 肺部疾病
Michael R Holt1, Timothy Baird2
1Gallipoli Medical Research Foundation, The University of Queensland, Brisbane, Queensland, Australia; Department of Thoracic Medicine, Royal Brisbane & Women's Hospital, Butterfield Street, Herston, Brisbane, Queensland, Australia.
Clinics in chest medicine
|October 27, 2023
概括
由于抗生素耐药性,Mycobacterium的肺部疾病很难治疗,导致结果不佳. 新的疗法和手术选择显示出改善治疗疗效和耐受性的前景.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 由于抗生素耐药性很高,Mycobacterium的肺部疾病带来了重大治疗挑战.
- 目前的抗生素方案提供有限的疗效,并与实质性的药物毒性有关.
- 宏类敏感性是患者预后的一个关键决定因素.
研究的目的:
- 审查当前Mycobacterium的肺部疾病治疗的情况.
- 确定关键的挑战和新兴的治疗策略.
- 评估手术干预在耐火病例中的作用.
主要方法:
- 对当前和新兴的Mycobacterium肺病治疗方法的文献综述.
- 对预后因素的分析,包括对类物质的敏感性.
- 评估与手术切除相关的结果.
主要成果:
- 在Mycobacterium的高抗生素耐药性需要新的治疗方法.
- 宏类敏感性是影响治疗成功的关键因素.
- 在专门的中心进行手术切除可以在特定患者中产生良好的结果.
- 新兴的治疗候选药物提供了提高疗效和降低毒性的潜力.
结论:
- 治疗Mycobacterium的肺部疾病仍然具有挑战性,结果不佳.
- 优化药物组合,持续时间和耐药性疾病的管理需要进一步的研究.
- 外科手术对于某些患者来说是一个可行的选择.
- 有希望的新疗法正在开发中,以改善患者护理.
相关概念视频
Pulmonary Tuberculosis V
183
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
183
Pulmonary Tuberculosis IV
145
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
145
Pulmonary Tuberculosis II
243
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
243
Pneumonia IV: Management
338
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
338
Pulmonary Tuberculosis III
339
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
339
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K


